Tiratricol sodiumProduct ingredient for Tiratricol

Name
Tiratricol sodium
Drug Entry
Tiratricol

A metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome.

Accession Number
DBSALT002405
Structure
Synonyms
Not Available
UNII
3HK9045D54
CAS Number
1477-04-9
Weight
Average: 643.917
Monoisotopic: 643.74544
Chemical Formula
C14H8I3NaO4
InChI Key
BBBAIWCYEJXUMH-UHFFFAOYSA-M
InChI
InChI=1S/C14H9I3O4.Na/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20;/h1-4,6,18H,5H2,(H,19,20);/q;+1/p-1
IUPAC Name
sodium 4-[4-(carboxymethyl)-2,6-diiodophenoxy]-2-iodobenzen-1-olate
SMILES
[Na+].OC(=O)CC1=CC(I)=C(OC2=CC(I)=C([O-])C=C2)C(I)=C1
ChemSpider
2282551
Predicted Properties
PropertyValueSource
Water Solubility0.00368 mg/mLALOGPS
logP4.43ALOGPS
logP5.59Chemaxon
logS-5.2ALOGPS
pKa (Strongest Acidic)2.31Chemaxon
pKa (Strongest Basic)-3.7Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area69.59 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity116.23 m3·mol-1Chemaxon
Polarizability40.16 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon